This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Feb;12(2):120-1; author reply 121.

doi: 10.1016/S1470-2045(11)70020-1.

Bortezomib-induced peripheral neuropathy: facts and genes

Guido Cavaletti

PMID: 21277549
DOI: 10.1016/S1470-2045(11)70020-1

Comment

Bortezomib-induced peripheral neuropathy: facts and genes

Guido Cavaletti. Lancet Oncol. 2011 Feb.

. 2011 Feb;12(2):120-1; author reply 121.

doi: 10.1016/S1470-2045(11)70020-1.

Author

Guido Cavaletti

PMID: 21277549
DOI: 10.1016/S1470-2045(11)70020-1

No abstract available

PubMed Disclaimer

Comment on

Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial.
Broyl A, Corthals SL, Jongen JL, van der Holt B, Kuiper R, de Knegt Y, van Duin M, el Jarari L, Bertsch U, Lokhorst HM, Durie BG, Goldschmidt H, Sonneveld P. Broyl A, et al. Lancet Oncol. 2010 Nov;11(11):1057-65. doi: 10.1016/S1470-2045(10)70206-0. Epub 2010 Sep 21. Lancet Oncol. 2010. PMID: 20864405 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information